Position in ACAD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$50,600
+$6,080 QoQ
Shares Held
2,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#262
of 352 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Nemes Rush Group LLC holds $3,327,523 across 17 Biotechnology names. ACAD ranks #5 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,579 | $2,771,256 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
5,165 | $201,486 | |
| 3 | SLS |
SELLAS Life Sciences Group, Inc.
|
10,000 | $147,600 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
2,000 | $109,880 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
This page
|
2,000 | $50,600 | |
| 6 | DNLI |
Denali Therapeutics Inc.
|
700 | $18,004 | |
| 7 | CRMD |
CorMedix Inc.
|
2,000 | $15,700 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8 | $4,988 |
All Filings in ACAD
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,600 | 2,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $44,520 | 2,000 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $53,420 | 2,000 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $42,680 | 2,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $43,140 | 2,000 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $33,220 | 2,000 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $36,700 | 2,000 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $30,760 | 2,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $32,500 | 2,000 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $36,980 | 2,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $62,620 | 2,000 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $41,680 | 2,000 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $47,900 | 2,000 | Shares | Sole | 2023-08-02 | |
| No filing history on record for this holder in this stock. | ||||||